OM1 Raises $15M in Series A Funding
Thursday, April 6, 2017
Big Data & Analytics
Healthcare & Pharma
Deal Type: 

OM1, a leading healthcare technology company focused on providing outcomes measurement and predictive analytics for value-based and personalized healthcare, today confirmed that it raised a series A financing round of $15 million led by General Catalyst and with participation from Glikvest, 7wire Ventures and Wanxiang Healthcare Investments. With the funding, OM1 will continue the buildout of its outcomes measurement and machine learning technology giving healthcare stakeholders a more holistic view and better understanding of real-world outcomes than has not been available until now.

Healthcare providers increasingly seek to better understand individual patient outcomes and to deliver more precise care. Life sciences researchers are looking for deeper clinical insights into the patient journey and the effectiveness and safety of their products. Simultaneously, insurers, including the federal government, are exploring value and outcomes-based payment models. OM1 has created a scientifically robust and clinically meaningful approach that provides a detailed level of outcomes information by leveraging big clinical data and artificial intelligence (AI) to enable stakeholders across the healthcare ecosystem to have more precise information for better decision-making... READ MORE